Cipla Ltd.
BSE: 500087 | Sector: Health care |
NSE: CIPLA | ISIN Code: INE059A01026 |
BSE 00:00 | 24 Apr | Cipla Ltd |
NSE 05:30 | 01 Jan | Cipla Ltd |
OPEN | 589.80 |
PREVIOUS CLOSE | 586.65 |
VOLUME | 421036 |
52-Week high | 615.55 |
52-Week low | 356.75 |
P/E | 20.59 |
Mkt Cap.(Rs cr) | 48,343 |
Buy Price | 595.10 |
Buy Qty | 1.00 |
Sell Price | 599.60 |
Sell Qty | 968.00 |
Cipla Ltd. (CIPLA) - Competition
COMPANY | Last Price | Market Cap. (Rs. cr.) |
Sales Turnover | Net Profit | Total Assets |
Sun Pharma.Inds. | 485.25 | 116,426.03 | 10,303.21 | 816.60 | 29,456.44 |
Dr Reddy's Labs | 4,002.25 | 66,509.39 | 10,625.50 | 1,277.30 | 13,831.90 |
Divi's Lab. | 2,428.65 | 64,468.51 | 4,879.66 | 1,332.65 | 7,092.08 |
Cipla | 599.60 | 48,342.75 | 12,374.01 | 1,888.41 | 16,007.89 |
Biocon | 357.25 | 42,870.00 | 2,884.70 | 492.70 | 7,317.10 |
Torrent Pharma. | 2,431.60 | 41,147.54 | 5,762.48 | 745.42 | 10,815.02 |
Lupin | 877.25 | 39,743.81 | 11,356.32 | 1,538.83 | 17,431.83 |
Aurobindo Pharma | 623.95 | 36,557.23 | 12,257.89 | 1,529.73 | 15,893.06 |
Abbott India | 16,438.55 | 34,931.92 | 3,678.60 | 450.33 | 2,084.02 |
Cadila Health. | 336.95 | 34,493.57 | 6,492.70 | 1,602.10 | 12,165.70 |
Alkem Lab | 2,737.25 | 32,723.82 | 5,714.09 | 799.84 | 6,146.23 |
Glaxosmi. Pharma | 1,454.45 | 24,639.84 | 3,128.53 | 425.36 | 2,458.71 |
Ipca Labs. | 1,615.95 | 20,417.53 | 3,633.15 | 454.91 | 3,607.71 |
Pfizer | 4,399.65 | 20,128.40 | 2,081.50 | 429.05 | 3,048.57 |
Piramal Enterp. | 865.20 | 19,514.59 | 3,671.40 | -861.98 | 37,161.89 |
Apollo Hospitals | 1,358.05 | 18,893.19 | 8,336.66 | 302.76 | 7,125.33 |
Sanofi India | 7,568.15 | 17,429.45 | 2,768.30 | 380.60 | 2,268.30 |
Alembic Pharma | 759.35 | 14,313.75 | 3,660.27 | 611.21 | 3,823.02 |
Ajanta Pharma | 1,444.55 | 12,603.70 | 1,772.62 | 391.76 | 2,155.85 |
Dr Lal Pathlabs | 1,496.25 | 12,469.75 | 1,164.90 | 195.44 | 932.07 |
Quick Links for Cipla:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices